Diuretic therapy for critically ill patients: a systematic review and network meta-analysis. [PDF]
Kuriyama A +14 more
europepmc +1 more source
Unchalee Permsuwan,1,2 Krit Leemasawat,3 Poukwan Arunmanakul1,2,4 1Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; 2Center for Medical and Health Technology Assessment (CM-HTA), Department of ...
Permsuwan U, Leemasawat K, Arunmanakul P
doaj
The effect of tolvaptan on total kidney volume and inflammatory markers in autosomal dominant polycystic kidney disease. [PDF]
Oruc M +4 more
europepmc +1 more source
A Rare Case of Preeclampsia-Associated Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in Twin Pregnancy Treated With Tolvaptan. [PDF]
Gilmore N +4 more
europepmc +1 more source
Species, cell proliferation state and oxygen partial pressure are major factors in the in vitro toxicity of repurposed potential ADPKD drugs in human and murine renal proximal tubule cells. [PDF]
Sotiropoulou P +5 more
europepmc +1 more source
GLUT9b- and ABCG2-mediated collecting duct urate transport uncovers a vasopressin-independent mechanism of renal water reabsorption. [PDF]
Hadla M +11 more
europepmc +1 more source
Development of Orally Disintegrating Tablets from Solid Dispersions Containing Tolvaptan/Cyclodextrin Complexes [PDF]
Kara AA, Tort S, Acartürk F.
europepmc +1 more source
Syndrome of inappropriate antidiuretic hormone secretion following immune effector cell-associated neurotoxicity syndrome during blinatumomab therapy: a case report. [PDF]
Yoshihara M +3 more
europepmc +1 more source
Baseline hematuria in autosomal dominant polycystic kidney disease. [PDF]
Serra A +3 more
europepmc +1 more source
Successful treatment of chronic alcohol-induced refractory hyponatremia with tolvaptan: a case report with in-depth analysis of traditional treatment failure mechanisms. [PDF]
Yan K +6 more
europepmc +1 more source

